FDA Inspection
Pharmaceutics International, Inc.Pharmaceutics International, Inc. – FDA Inspection, Nov 14, 2022
Record Details
This FDA Inspection record concerns Pharmaceutics International, Inc., with an inspection on November 14, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- November 14, 2022
- Product Type
- Drugs
View Company Profile
ID · c233b238-eb27-4d58-99dc-abe21668f706
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1194409
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Pharmaceutics International, Inc.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| March 6, 2026 | Not classified | Baltimore District Office | Drug Quality Assurance |
| June 12, 2024 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| September 29, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 10, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 9, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pharmaceutics International, Inc.
- FDA Inspection 1307080 - 2026-03-06
- FDA Inspection 1244595 - 2024-06-12
- FDA Inspection 1155191 - 2021-09-29
- FDA Inspection 1124545 - 2020-07-10
- FDA Inspection 1072073 - 2018-11-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.